# Crossover Blinded Trial of Cell Therapy Versus Placebo in COPD

> **NCT03228121** · NA · WITHDRAWN · sponsor: **Lung Institute**

## Conditions studied

- COPD
- Emphysema or COPD
- Chronic Bronchitis

## Interventions

- **PROCEDURE:** Treatment Then Placebo
- **PROCEDURE:** Placebo Then Treatment

## Key facts

- **NCT ID:** NCT03228121
- **Lead sponsor:** Lung Institute
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-04-24
- **Primary completion:** 2018-09-11
- **Final completion:** 2018-09-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Enrollment did not meet expectations
- **Last updated:** 2018-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03228121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03228121, "Crossover Blinded Trial of Cell Therapy Versus Placebo in COPD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03228121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*